Technical Specifications
| Drug Composition | Gefitinib 250 mg |
|---|---|
| Variant / Strength | 250 mg |
| Dosage Form / Type | Tablets |
| Product Benefits | Non-small cell lung cancer |
| Packaging Type | Bottle |
| Delivery Time | 7 - 15 Days, as per delivery location. |
| Country of Origin | Made in India |
| Export Destinations | USA, UK, UAE, Philippines, Thailand, Kenya, Nigeria, Germany, Canada, Mexico, and 65+ more countries |
| Export Route | Shipped via temperature-controlled international air courier with full customs documentation |
Product Overview & Description
The tablet is prescribed for treating non-small cell lung cancer in patients where the cancer has metastasized, who possess abnormal epidermal growth factor receptor (EGFR) genes, and have not undergone prior cancer treatment.
Submit Quotation Request
Verified Customer Reviews (0)
Frequently Asked Questions
ℹ️ Information reviewed by Medibliss Lifesciences Editorial Team. Last reviewed: August 2026. Data sourced from manufacturer documentation and WHO-GMP certificates.
Disclaimer: The information provided on this page is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Medibliss Lifesciences acts solely as an exporter and supplier. Please consult your physician or a qualified healthcare provider before starting any medication. We do not manufacture these products and rely on the manufacturer's provided documentation and WHO-GMP certifications for product information.